市值超4800亿元的药企股价涨逾4%: 这款“癌王”突破疗法要来中国了

第一财经
Aug 11

8月11日上午,百济神州(ONC.US、06160.HK、688235.SH)A股以及港股股价涨幅超过4%,其中A股市值达到4820亿元。  盘面上,公司前一晚与Revolution Medicines宣布达成临床开发及区域商业化合作。  临床合作将探索百济神州部分肿瘤候选药物与Revolution Medicines四款处于临床阶段、用于RAS驱动型癌症的RAS(ON)抑制剂的创新联合治疗方案。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10